Live Chat

MerckCo लाइव चार्ट

उपकरण मूल बातें

Weekly Search
Weekly
Daily
दिनांक बंद करें परिवर्तन (%) परिवर्तित करें खुला उच्च कम

जानकारी

स्प्रेड

0.67

स्प्रेड (%)

0.6188 %

लीवरेज

1:10

ओवरनाइट ब्याज विक्रय

-0.0597 %

overnight_interest_sell

-0.0292 %

मुद्रा

USD

ट्रेडिंग घंटे

बाज़ार बंद है

सोमवार

13:31 - 19:59

मंगवार

13:31-19:59

बुधवार

13:31-19:59

गुरुवार

13:31-19:59

शुक्रवार

13:31-19:59

विश्लेषण और सांख्यिकी

खुला

---

पिछला बंद

---

52 सप्ताह उच्च/निम्न्च

--- – ---

बाज़ार आकार

258221506560

बकाया शेयर

2534810112

प्राप्ति की तिथि (आगे)

2021-06-03

लाभांश आय 

2024-10-07

पूर्व-लाभांश तिथि

2024-09-16

अग्रिम वार्षिक लाभांश दर 

3.08

अग्रिम वार्षिक लाभांश आय

0.0302

EPS

4.77

इस उपकरण के बारे में अधिक जानें

MerckCo USA Merck & Company Inc
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, wholesalers, government entities, veterinarians, distributors, animal producers, farmers, and pet owners. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

संबंधित उपकरण

संपत्ति
बेचें
खरीदें
(%) परिवर्तित करें
view_all_instruments

नवीनतम समाचार

दुनिया भर की लेटेस्ट फ़ाइनेंशियल न्यूज़ से अपडेटेड रहें।

बुधवार, 6 नवंबर 2024

U.S. presidential election market volatility drives Bitcoin prices to reach a historic high

Stock market rally

मंगवार, 5 नवंबर 2024

US Election Results Trigger Stock Gains Across Europe, Asia, and US

US Election Trump's victory

मंगवार, 5 नवंबर 2024

Trump Victory Spurs Market Gains and Economic Shift Expectations

मंगवार, 5 नवंबर 2024

US election: bitcoin price (BTC) surged to new record as Trump leading ahead

मंगवार, 5 नवंबर 2024

Stock Market Today: Wall Street Rallies on Election Day Amid Strong Economic Outlook

US Election 2024 Trump

मंगवार, 5 नवंबर 2024

Early Election Results Shift Markets as Trump’s Chances Rise

सोमवार, 4 नवंबर 2024

Stock Market Today: S&P 500 Declines as Investors Brace for US Election

सोमवार, 4 नवंबर 2024

US election: What will happen to tesla stock if Trump wins?

Trustpilot
Live Chat